serpin family G member 1
Dernière mise à jour 11 mars 2024
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
The SERPING1 gene provides instructions for making a protein called C1 inhibitor (C1-INH), which is a type of serine protease inhibitor (serpin). Serpins help control several types of chemical reactions by blocking the activity of certain proteins. C1-INH is important for controlling a range of processes involved in maintaining blood vessels, including inflammation. Inflammation is a normal body response to infection, irritation, or injury.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
The SERPING1 gene provides instructions for making a protein called C1 inhibitor (C1-INH), which is a type of serine protease inhibitor (serpin). Serpins help control several types of chemical reactions by blocking the activity of certain proteins. C1-INH is important for controlling a range of processes involved in maintaining blood vessels, including inflammation. Inflammation is a normal body response to infection, irritation, or injury.
C1-INH blocks the activity of several proteins in the blood, including plasma kallikrein and the activated form of factor XII (called factor XIIa). These two proteins are involved in the production of bradykinin. Bradykinin is a protein fragment (peptide) that promotes inflammation by allowing fluids to leak through blood vessel walls into body tissues (vascular permeability). C1-INH attaches (binds) to plasma kallikrein and factor XIIa, which prevents them from completing any further reactions. These proteins are cleared from the bloodstream once they are bound to C1-INH.
Conditions referring to this gene or chromosome
Other names
C1-INH
C1IN
C1INH
C1NH
complement component 1 inhibitor
IC1_HUMAN
plasma protease C1 inhibitor
serine/cysteine proteinase inhibitor clade G member 1
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1
Related patient information and medicines

Patient information leaflet
Puis-je prendre le Fénofibrate et le Gabapentine ensemble ?
Il y a no known significant interactions between fenofibrate and gabapentin. These two medicines work in different ways and are processed by different organs in the body. Why this happens Fenofibrate is primarily broken down by the liver and affects blood fats (lipids). Gabapentin is not metabolised by the liver; it is filtered out of the body.

Patient information leaflet
Cancer du sein chez les hommes
Men can get cancer of the breast becau... Certain things can make the condition more likely, such as: Age. Breast cancer in men tends to develop in older men, usually between the ages of 60 and 70. Antécédents familiaux. Some breast cancers are caused by a flawed gene. The main gene which can cause men to be more at risk of breast cancer is the BRCA2.

Patient information leaflet
Faits et facteurs de risque du cancer du sein
What are the risk factors for breast cancer. Dr Sarah Jarvis MBE Although cancer du sein can develop for no apparent reason, there are certain facteurs de risque which increase the chance that breast cancer will develop. /health/breast-cancer-leaflet Most cases of breast le cancer occur by chance. However, breast cancer does occur more.

Patient information leaflet
dystrophie musculaire
dystrophie musculaire est un inherited (genetic) disorder causing muscle weakness. There are different types of muscular dystrophy, which vary as to how severe they are, ranging from very mild to severe. The different types also vary as to what age they begin. What is muscular dystrophy. Muscular dystrophy (MD) is the name given to a group of.

Patient information leaflet
Glaucome
Family d... Glaucoma is rare at the age of 40, only affecting about 1 in 300 people. By the age of 70, about 1 in 33 people in the UK have glaucoma. Glaucoma is unusual in people under the age of 35. Glaucome can affect anyone but it is more common if you: Have a family history of glaucoma (if a parent, brother or sister has glaucoma, you are 2-4.

Patient information leaflet
Maladie de Huntington
If you know that you have a family history of Huntington's disease, make sure that you mention that at the appointment. What causes Huntington's disease. Maladie de Huntington est caused by a defective gene that you inherit from your parents. Maladie de Huntington est un autosomal dominant condition, meaning you can inherit the disease from just one.
Lectures complémentaires et références
- serpin family G member 1; MedlinePlus, National Library of Medicine.
- Busse PJ, Christiansen SC, Riedl MA, Banerji A, Bernstein JA, Castaldo AJ, Craig T, Davis-Lorton M, Frank MM, Li HH, Lumry WR, Zuraw BL. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. J Allergy Clin Immunol Pract. 2021 Jan;9(1):132-150.e3. doi: 10.1016/j.jaip.2020.08.046. Epub 2020 Sep 6.
- Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med. 2009 Feb;15(2):69-78. doi: 10.1016/j.molmed.2008.12.001. Epub 2009 Jan 21.
- Gosswein T, Kocot A, Emmert G, Kreuz W, Martinez-Saguer I, Aygoren-Pursun E, Rusicke E, Bork K, Oldenburg J, Muller CR. Mutational spectrum of the C1INH (SERPING1) gene in patients with hereditary angioedema. Cytogenet Genome Res. 2008;121(3-4):181-8. doi: 10.1159/000138883. Epub 2008 Aug 28.
- Pappalardo E, Caccia S, Suffritti C, Tordai A, Zingale LC, Cicardi M. Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates. Mol Immunol. 2008 Aug;45(13):3536-44. doi: 10.1016/j.molimm.2008.05.007. Epub 2008 Jun 30.
- Sinnathamby ES, Issa PP, Roberts L, Norwood H, Malone K, Vemulapalli H, Ahmadzadeh S, Cornett EM, Shekoohi S, Kaye AD. Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology. Adv Ther. 2023 Mar;40(3):814-827. doi: 10.1007/s12325-022-02401-0. Epub 2023 Jan 7.
- Veronez CL, Csuka D, Sheikh FR, Zuraw BL, Farkas H, Bork K. The Expanding Spectrum of Mutations in Hereditary Angioedema. J Allergy Clin Immunol Pract. 2021 Jun;9(6):2229-2234. doi: 10.1016/j.jaip.2021.03.008. Epub 2021 Mar 19.
- Wouters D, Wagenaar-Bos I, van Ham M, Zeerleder S. C1 inhibitor: just a serine protease inhibitor? New and old considerations on therapeutic applications of C1 inhibitor. Expert Opin Biol Ther. 2008 Aug;8(8):1225-40. doi: 10.1517/14712598.8.8.1225.
- Zuraw BL. Clinical practice. Hereditary angioedema. N Engl J Med. 2008 Sep 4;359(10):1027-36. doi: 10.1056/NEJMcp0803977. No abstract available.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

